Insiders · INZY

INZY insider transactions

Inozyme Pharma Inc. (INZY) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for INZY

• 335d
  SVP, CFO & Head of BD Subramanian Sanjay closing all direct ownership in the company (SEC Form 4)

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 335d
  COO Winton Matthew closing all direct ownership in the company (SEC Form 4)

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 335d
  Director Bolte Axel closing all direct ownership in the company (SEC Form 4)

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 335d
  SEC Form 4 filed by Director Sullivan Lynne Marie

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 335d
  CEO & Chairman Treco Douglas A closing all direct ownership in the company (SEC Form 4)

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 335d
  SEC Form 4 filed by Director Hopfner Robert Lorne

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 341d
  COO Winton Matthew was granted 14,355 shares, increasing direct ownership by 194% to 21,743 units (SEC Form 4)

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 341d
  CEO & Chairman Treco Douglas A was granted 2,815 shares, increasing direct ownership by 7% to 43,861 units (SEC Form 4)

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 341d
  SVP, CFO & Head of BD Subramanian Sanjay was granted 6,813 shares, increasing direct ownership by 21% to 39,701 units (SEC Form 4)

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 379d
  Director Bolte Axel exercised 157,230 shares at a strike of $0.98, increasing direct ownership by 59% to 423,926 units (SEC Form 4)

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 426d
  CEO & Chairman Treco Douglas A converted options into 25,000 shares and sold $7,849 worth of shares (8,819 units at $0.89), increasing direct ownership by 65% to 41,046 units (SEC Form 4)

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 427d
  COO Winton Matthew was granted 2,490 shares, increasing direct ownership by 51% to 7,388 units (SEC Form 4)

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 427d
  SVP, CFO & Head of BD Subramanian Sanjay was granted 2,490 shares, increasing direct ownership by 8% to 32,888 units (SEC Form 4)

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 443d
  SEC Form 4 filed by SVP, CFO Subramanian Sanjay

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 443d
  SEC Form 4 filed by COO Winton Matthew

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 443d
  SEC Form 4 filed by CEO Treco Douglas A

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 604d
  SEC Form 4 filed by Director Harris Erik

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 604d
  SEC Form 3 filed by new insider Harris Erik

  3 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 608d
  CEO Treco Douglas A was granted 1,710 shares, increasing direct ownership by 8% to 22,375 units (SEC Form 4)

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 608d
  COO Winton Matthew was granted 1,710 shares, increasing direct ownership by 54% to 4,898 units (SEC Form 4)

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 713d
  SEC Form 4 filed by Director Mathers Edward T

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 713d
  SEC Form 4 filed by Director Hopfner Robert Lorne

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 713d
  SEC Form 4 filed by Director Diaz Reinaldo M

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 713d
  SEC Form 4 filed by Director Sullivan Lynne Marie

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 713d
  SEC Form 4 filed by Director Bhagat Sarah M

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 713d
  SEC Form 4 filed by Director Bolte Axel

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 713d
  SEC Form 4 filed by Director Edwards Martin

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 791d
  Treco Douglas A sold $52,210 worth of shares (7,523 units at $6.94) and converted options into 25,000 shares, increasing direct ownership by 548% to 20,665 units (SEC Form 4)

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 791d
  Winton Matthew was granted 3,188 shares (SEC Form 4)

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 810d
  SEC Form 4 filed by Subramanian Sanjay

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 810d
  SEC Form 4 filed by Treco Douglas A

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 810d
  SEC Form 4 filed by Winton Matthew

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 974d
  Subramanian Sanjay was granted 2,319 shares, increasing direct ownership by 8% to 30,398 units (SEC Form 4)

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 1035d
  SEC Form 4: Pivotal Bioventure Partners Fund I, L.P. bought $3,999,998 worth of shares (833,333 units at $4.80)

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 1035d
  SEC Form 4: Hopfner Robert Lorne bought $3,999,998 worth of shares (833,333 units at $4.80)

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 1084d
  SEC Form 4 filed by Mathers Edward T

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 1084d
  SEC Form 4 filed by Sullivan Lynne Marie

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 1084d
  SEC Form 4 filed by Bolte Axel

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 1084d
  SEC Form 4 filed by Hopfner Robert Lorne

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 1084d
  SEC Form 4 filed by Edwards Martin

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 1084d
  SEC Form 4 filed by Diaz Reinaldo M

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 1084d
  SEC Form 4 filed by Bhagat Sarah M

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 1115d
  SEC Form 4 filed by Hopfner Robert Lorne

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 1127d
  SEC Form 4 filed by Bolte Axel

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 1156d
  SEC Form 4 filed by Treco Douglas A

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 1156d
  SEC Form 4 filed by Bolte Axel

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 1156d
  SEC Form 4 filed by Subramanian Sanjay

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 1156d
  SEC Form 4 filed by Winton Matthew

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 1156d
  SEC Form 3 filed by new insider Winton Matthew

  3 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 1161d
  SEC Form 4 filed by Hopfner Robert Lorne

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 1162d
  SEC Form 4 filed by Hopfner Robert Lorne

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 1164d
  SEC Form 4 filed by Subramanian Sanjay

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 1262d
  SEC Form 4: Bjarke Henric Bjorn bought $29,885 worth of shares (21,500 units at $1.39), increasing direct ownership by 26% to 105,441 units

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 1338d
  SEC Form 4: Bjarke Henric Bjorn was granted 3,315 shares, increasing direct ownership by 4% to 83,941 units

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 1338d
  SEC Form 4: Bolte Axel was granted 3,315 shares, increasing direct ownership by 1% to 261,890 units

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 1450d
  SEC Form 4 filed by Mathers Edward T

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 1450d
  SEC Form 4 filed by Treco Douglas A

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 1450d
  SEC Form 4 filed by Sullivan Lynne Marie

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 1450d
  SEC Form 4 filed by Hopfner Robert Lorne

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)
• 1450d
  SEC Form 4 filed by Edwards Martin

  4 - Inozyme Pharma, Inc. (0001693011) (Issuer)